Package 69097-914-02

{"route": ["ORAL"], "spl_id": "d7eae0fc-9dfd-48d5-9491-e785fd66d5ec", "openfda": {"nui": ["N0000175525", "N0000000147", "N0000182140"], "upc": ["0369097914028", "0369097913021"], "unii": ["KG60484QX9", "8MDF5V39QO"], "rxcui": ["616539", "616541"], "spl_set_id": ["9cdde58a-ae8a-451f-92cf-cab178e4ba92"], "pharm_class_epc": ["Proton Pump Inhibitor [EPC]"], "pharm_class_moa": ["Proton Pump Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (69097-914-02)", "package_ndc": "69097-914-02", "marketing_start_date": "20170130"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (69097-914-12)", "package_ndc": "69097-914-12", "marketing_start_date": "20170130"}], "brand_name": "omeprazole sodium bicarbonate", "product_id": "69097-914_d7eae0fc-9dfd-48d5-9491-e785fd66d5ec", "dosage_form": "CAPSULE", "pharm_class": ["Alkalinizing Activity [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Proton Pump Inhibitor [EPC]", "Proton Pump Inhibitors [MoA]"], "product_ndc": "69097-914", "generic_name": "omeprazole sodium bicarbonate", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "omeprazole sodium bicarbonate", "active_ingredients": [{"name": "OMEPRAZOLE", "strength": "40 mg/1"}, {"name": "SODIUM BICARBONATE", "strength": "1100 mg/1"}], "application_number": "ANDA207476", "marketing_category": "ANDA", "marketing_start_date": "20170130", "listing_expiration_date": "20261231"}